Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma

NCT00536835

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: GSK Investigational Site Sutton, Surrey, United Kingdom

GSK Investigational Site Belfast, Northern Ireland, United Kingdom

GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

NCT02381080

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +28 more
Locations: N/a N/a, Canada

Moscow, Russia

Petrozavodsk, Russia

Saint Petersburg, Russia

View Trial Details

Completed

Copanlisib Pharmacodynamic Study

NCT02155582

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Bruxelles - Brussel, Belgium

Bruxelles - Brussel, Belgium

Ghent, Belgium

Caen, France

View Trial Details

Completed

A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma

NCT01290549

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: Stanford Cancer Center Stanford, California, United States

Stanford Cancer Institute Pharmacy Stanford, California, United States

Florida Cancer Specialists; Sarasota Sarasota, Florida, United States

Roswell Park Cancer Inst. Buffalo, New York, United States

View all 16 locations

View Trial Details

Completed

High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas

NCT00895661

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

NCT02859207

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Miami, Florida, United States

Orlando, Florida, United States

Minneapolis, Minnesota, United States

View Trial Details

Completed

Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma

NCT02105012

Conditions: Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: Pearl Therapeutics Study Site Athens, Alabama, United States

Pearl Therapeutics Study Site Birmingham, Alabama, United States

Pearl Therapeutics Study Site Foley, Alabama, United States

Pearl Therapeutics Study Site Los Angeles, California, United States

View all 41 locations

View Trial Details

Completed

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

NCT00241358

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

NCT01158118

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +31 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT01466153

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Burbank, California, United States

Research Site La Jolla, California, United States

Research Site Palm Springs, California, United States

View all 54 locations

View Trial Details